Vanda: Q4 Financial Results Overview

Vanda Pharmaceuticals Reports Fourth Quarter Financial Results

Vanda Pharmaceuticals Inc., headquartered in Washington, announced on Wednesday that it experienced a net loss of $141.2 million during the fourth quarter.

The company’s loss translated to $2.39 per share, while the loss per share excluding one-time expenses was 46 cents.

During this period, Vanda Pharmaceuticals generated $57.2 million in revenue.

For the full year, the company reported a total loss of $220.5 million, or $3.74 per share, with annual revenue reaching $216.1 million.